N,N'- ((1,1'- biphenyl)- 4,4'- di- (1- propyn- 3- yl))- bis(3,4- dimethylpyridinum)

an alpha9alpha10 nicotinic receptor antagonist

Also Known As:

N,N'-((1,1'-biphenyl)-4,4'-di-(1-propyn-3-yl))-bis(3,4-dimethylpyridinum) bromide; ZZ1-61C

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Neuralgia (Stump Neuralgia) 09/01/2012 - "This study suggests that ZZ1-61c, a novel compound with a unique mechanism of antagonistic action at the α9α10 nAChR, may be a potential drug candidate for prevention and attenuation of neuropathic pain resulting from chemotherapy. "
2.	Muscle Weakness 09/01/2012 - "ZZ1-61c did not cause motor dysfunction (rotarod) or muscular weakness (the grip test). "

1.	Drug Therapy (Chemotherapy)